Pfizer Needs AstraZeneca More Than Ever as Generics Increase - Presented by: The Aol. On Network

Pfizer shares are slipping after the drug maker posted first-quarter profits 15 percent lower than a year earlier and revenue down 9 percent. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.85 0.32 ▲ 2.06%
AAPL $ 112.34 4.62 ▲ 4.29%
UAL $ 57.29 0.16 ▲ 0.28%
GE $ 24.57 0.69 ▲ 2.89%
AA $ 9.32 0.10 ▲ 1.08%
QQQ $ 103.90 2.85 ▲ 2.82%
NFLX $ 105.44 0.35 ▼ 0.33%
MSFT $ 43.36 1.54 ▲ 3.68%

As of 9/2/2015, 04:15 PM